EcoDrugPlus

Glutamate Receptor 1-Like

Ensembl ID : ENSPKIG00000006257
Gene Symbol: LOC111848932
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSPKIG00000018816
Gene Symbol: LOC111850515
3 Cross references
250 Possible Orthologues:

Glutamate Receptor 2

Ensembl ID : ENSPKIG00000015050
Gene Symbol: LOC111833296
4 Cross references
180 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSPKIG00000014866
Gene Symbol: LOC111855332
3 Cross references
180 Possible Orthologues:

Glutamate Receptor 4-Like

Ensembl ID : ENSPKIG00000003024
Gene Symbol: LOC111854368
3 Cross references
252 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSPKIG00000000455
Gene Symbol: LOC111833407
3 Cross references
151 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSPKIG00000012197
Gene Symbol: LOC111853980
3 Cross references
206 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSPKIG00000007768
Gene Symbol: LOC111837764
2 Cross references
214 Possible Orthologues:

Glutaminase

Ensembl ID : ENSPKIG00000015269
Gene Symbol: GLS
4 Cross references
301 Possible Orthologues:

Glutaminase

Ensembl ID : ENSPKIG00000008968
Gene Symbol: GLS
4 Cross references
302 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSPKIG00000014769
Gene Symbol: GSTP1
3 Cross references
160 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSPKIG00000001929
Gene Symbol: GSTP1
3 Cross references
143 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).